Evidence map›Paper›PMID 11483763›Full record

ArticleJournal of virology2001

Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection.

D M Blau, C Turbide, M Tremblay, M Olson, S Létourneau, E Michaliszyn, S Jothy, K V Holmes, N Beauchemin

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. The molecular virology of coronaviruses.The Journal of biological chemistry · 2020
    Review
  9. Article
  10. CEACAM1 in Liver Injury, Metabolic and Immune Regulation.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Identification of anti-viral activity of the cardenolides, NaToxicology and applied pharmacology · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

D M BlauDepartment of Microbiology, University of Colorado Health Sciences Center, Denver, Colorado, USA.
C Turbide
M Tremblay
M Olson
S Létourneau
E Michaliszyn
S Jothy
K V Holmes
N Beauchemin
McGill University Health Centre · CAUniversity of Colorado Health · USAmgen (United States) · USHealth Sciences Centre · CAMcGill University · CA

Funding

MOLECULAR GENETICS OF THE RECEPTOR FOR MVHR01AI025231 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, KATHRYN V · 1988 to 2007
$3.5M
Molecular Basis of Microbial PathogenesisT32AI007537 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, RANDALL K · 1998 to 2007
$1.3M
NIAID NIH HHS AI25231NIAID NIH HHS R01 AI025231NIAID NIH HHS T32 AI007537NIAID NIH HHS T32 AI07537
6 · The paper itself

Abstract

The CEACAM1 glycoproteins (formerly called biliary glycoproteins; BGP, C-CAM, CD66a, or MHVR) are members of the carcinoembryonic antigen family of cell adhesion molecules. In the mouse, splice variants of CEACAM1 have either two or four immunoglobulin (Ig) domains linked through a transmembrane domain to either a short or a long cytoplasmic tail. CEACAM1 has cell adhesion activity and acts as a signaling molecule, and long-tail isoforms inhibit the growth of colon and prostate tumor cells in rodents. CEACAM1 isoforms serve as receptors for several viral and bacterial pathogens, including the murine coronavirus mouse hepatitis virus (MHV) and Haemophilus influenzae, Neisseria gonorrhoeae, and Neisseria meningitidis in humans. To elucidate the mechanisms responsible for the many biological activities of CEACAM1, we modified the expression of the mouse Ceacam1 gene in vivo. Manipulation of the Ceacam1 gene in mouse embryonic stem cells that contained the Ceacam1a allele yielded a partial knockout. We obtained one line of mice in which the insert in the Ceacam1a gene had sustained a recombination event. This resulted in the markedly reduced expression of the two CEACAM1a isoforms with four Ig domains, whereas the expression of the two isoforms with two Ig domains was doubled relative to that in wild-type BALB/c (+/+) mice. Homozygous (p/p) Ceacam1a-targeted mice (Ceacam1aDelta4D) had no gross tissue abnormalities and were viable and fertile; however, they were more resistant to MHV A59 infection and death than normal (+/+) mice. Following intranasal inoculation with MHV A59, p/p mice developed markedly fewer and smaller lesions in the liver than +/+ or heterozygous (+/p) mice. The titers of virus produced in the livers were 50- to 100-fold lower in p/p mice than in +/p or +/+ mice. p/p mice survived a dose 100-fold higher than the lethal dose of virus for +/+ mice. +/p mice were intermediate between +/+ and p/p mice in susceptibility to liver damage, virus growth in liver, and susceptibility to killing by MHV. Ceacam1a-targeted mice provide a new model to study the effects of modulation of receptor expression on susceptibility to MHV infection in vivo.

Indexed as

Disease SusceptibilityAnimalsAntigens, CDCarcinoembryonic AntigenCell Adhesion MoleculesGene TargetingGenetic EngineeringGlycoproteinsHepatitis, Viral, AnimalKidneyLiverMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMurine hepatitis virusAntigens, CDCarcinoembryonic AntigenCD66 antigensCeacam1 protein, mouseCell Adhesion MoleculesGlycoproteinsReceptors, Virus

Identifiers

PMID11483763
PMCPMC115062
OpenAlexW2127064732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.